LimFlow System's 6-Month Outcomes Presented From the PROMISE II US Pivotal Trial
November 4, 2022—Six-month results from the PROMISE II United States pivotal trial of transcatheter arterialization of the deep veins with the L
Stay updated with breaking news from Daniel Clair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
November 4, 2022—Six-month results from the PROMISE II United States pivotal trial of transcatheter arterialization of the deep veins with the L
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
The second round of late-breaking clinical trial results were presented at VIVA22 on Nov. 1 in Las Vegas, NV.
A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional Strategies) 2022 Conference Oct. 30-31, and the VIVA22, Oct. 31-Nov. 3 in Las Vegas, NV, recognizing specialists in endovascular medicine.
/PRNewswire/ -- VESTECK, Inc. is pleased to announce the expansion of their Scientific Advisory Board with the addition of Dr. Dai Yamanouchi. Dr Yamanouchi, a...